Science 37 Holdings, Inc.
SNCE · NASDAQ
12/31/2022 | 12/31/2021 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Revenue | $70 | $60 | $24 | $0 |
| % Growth | 17.7% | 151.4% | – | – |
| Cost of Goods Sold | $54 | $42 | $23 | $0 |
| Gross Profit | $16 | $17 | $1 | $0 |
| % Margin | 22.6% | 28.9% | 4.7% | – |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $1 | $0 |
| SG&A Expenses | $103 | $73 | $28 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $28 | $0 |
| Other Operating Expenses | $18 | $8 | $4 | $0 |
| Operating Expenses | $121 | $81 | $33 | $0 |
| Operating Income | -$105 | -$64 | -$32 | $0 |
| % Margin | -150.2% | -106.9% | -133.7% | – |
| Other Income/Exp. Net | $54 | -$31 | $0 | -$0 |
| Pre-Tax Income | -$51 | -$94 | -$32 | -$0 |
| Tax Expense | -$0 | $0 | $1 | $0 |
| Net Income | -$51 | -$94 | -$32 | -$0 |
| % Margin | -72.7% | -158.3% | -136.6% | – |
| EPS | -0.44 | -2,886.59 | -2.18 | -0.002 |
| % Growth | 100% | -132,312.4% | -114,636.8% | – |
| EPS Diluted | -0.44 | -2,886.59 | -2.18 | -0.002 |
| Weighted Avg Shares Out | 116 | 0 | 15 | 1 |
| Weighted Avg Shares Out Dil | 116 | 0 | 15 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$34 | $39 | $5 | $0 |
| EBITDA | -$139 | -$25 | -$26 | $0 |
| % Margin | -198.7% | -41.3% | -111.7% | – |